|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 655 K Street NW, Suite 100 |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20001-2399 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 4493-12
|
||||||||
|
6. House ID# 312430000
|
TYPE OF REPORT | 8. Year | 2018 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Matthew Shick |
Date | 10/22/2018 4:26:20 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
H.R.2/S.3042, Agriculture Improvement Act of 2018
Issue: Support amendments to update the frequency of required inspections under the Animal Welfare Act (AWA).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tannaz |
Rasouli |
|
|
|
Christa |
Wagner |
PhD |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Presidents Budget, FY 2019
P.L. 115-141, Consolidated Appropriations Act of 2018, Division H
P.L. 115-123, Bipartisan Budget Act of 2018, Division B
S.3158/ H.R. 6470, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
P.L. 115-245, Department of Defense and Labor, Health and Human services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019, Division B
Issues: Support funding for National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), Childrens Hospitals Graduate Medical Education (CHGME), Centers for Disease Control and Prevention (CDC), the National Center for Health Statistics (NCHS), the Prevention and Public Health Fund (PPHF), Hospital Preparedness Program, and biodefense and public health preparedness programs. Oppose limitations on facilities and administrative reimbursement and on salary support. Maintain NIH salary cap at Executive Level II. Oppose reorganization of NIH and AHRQ without stakeholder input and deliberation. Oppose restrictions on fetal tissue and embryonic stem cell research. Encourage consideration of forthcoming NIH plan for chimp sanctuaries. Support funding for Health Resources and Services Administration (HRSA) workforce programs. Support funding for CDC Racial and Ethnic Approaches to Community Health program (REACH), Prevention Research Centers, and for research on gun violence. Support funding for Department of Education and federal student aid. Support funding to combat opioid epidemic. Support increased funding allocations for Labor-HHS-Education Subcommittee and oppose across-the-board cuts. Support single accreditation system for graduate medical education. Oppose cuts to graduate medical education.
P.L. 115-141, Consolidated Appropriations Act, 2018, Division F
P.L. 115-123, Bipartisan Budget Act of 2018, Division B
P.L.115-244, Energy and Water, Legislative Branch, and Military Construction and Veterans Affairs Appropriations Act, 2019
Issue: Support funding for Veterans Affairs medical research, research infrastructure, and community care. Oppose restrictions on use of canines in VA medical research. Support funding for DOD Congressionally Directed Medical Research Programs (CDMRP)
P.L. 115-141, Consolidated Appropriations Act, 2018, Division B
P.L. 115-123, Bipartisan Budget Act of 2018, Division B
S. 3072 / H.R 5952 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2019
Issue: Support funding for the National Science Foundation (NSF).
Issue: Oppose Medicare payment reductions as offsets for non-Medicare spending.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Health Resources & Services Administration (HRSA), Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Len |
Marquez |
|
|
|
Matthew |
Shick |
J.D. |
|
|
Tannaz |
Rasouli |
|
|
|
Jason |
Kleinman |
|
|
|
Karen |
Fisher |
J.D. |
|
|
Catherine |
Spivey |
JD |
|
|
Christa |
Wagner |
PhD |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
Issue: Educate Congress on perspectives from the higher education community regarding technology transfer, the importance of the Bayh-Dole Act to the US patent system, and the impact of sovereign immunity claims on challenges to patents.
H.R.5340, STRONGER Patents Act
Issue: Support efforts to improve and prevent abuse of the U.S. patent system
H.R. 6758/H.R. 6390, SUCCESS Act
Issue: Support legislation for USPTO to study and report on number of patents by various entities.
H.R.6505, Medicare Negotiation and Competitive Licensing Act of 2018
Issue: Support intellectual property protections.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Patent & Trademark Office (PTO), U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tannaz |
Rasouli |
|
|
|
Christa |
Wagner |
PhD |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Issues: Oppose cuts to graduate/professional student loan benefits, including Public Service Loan Forgiveness (PSLF).
H.R. 4223, Protecting Our Students by Terminating Graduate Rates that Add to Debt (POST GRAD) Act.
Issue: Support restoring graduate/professional subsidized student loans
S. 850 / H.R.1922, Foreign Medical School Accountability Fairness Act of 2017
Issue: Support transparency for all international medical schools.
H.R. 2373, To amend title XVIII of the Social Security Act
Issue: Support single accreditation system for graduate medical education
H.R. 4508, the Promoting Real Opportunity, Success, and Prosperity through Education Reform (PROSPER) Act
H.R.6543, Aim Higher Act
Issue: support graduate/professional student loan benefits, including PSLF. Oppose elimination of GradPLUS. Oppose requirement to separately incorporate specialized accrediting agencies.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Tannaz |
Rasouli |
|
|
|
Catherine |
Spivey |
J.D. |
|
|
Karen |
Fisher |
JD |
|
|
Leonard |
Marquez |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issue: Educate congressional staff on academic medicines missions, including education, research, patient care, GME, workforce, and physician shortages in rural and urban communities.
Issue: Support continuation of high-quality affordable health insurance through preservation of current levels of health care coverage. Support programs and funds for safety-net providers.
H.R. 3728, Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) Act of 2017
Issue: Support reauthorization of Title VII health professions programs
P.L. 115-241, Childrens Hospital GME Support Reauthorization Act
Issue: Support reauthorization of the Childrens Hospital GME program
H.R. 959/S. 1109 Title VIII Nursing Workforce Reauthorization Act of 2017
Issue: Support reauthorization of Title VIII nursing workforce development programs
S.3095 / H.R. 2574, Building a Health Care Workforce for the Future Act
Issue: Support bill to increase scholarship opportunities for medical students and encourage primary care workforce development
Issue: Educate Congress and support training on substance use disorders, pain management, and safe prescribing practices. Strategies to prevent, identify, and treat opioid addiction
Issue: Support reauthorization of the Patient Centered Outcomes Research Institute (PCORI) and the Patient Centered Outcomes Research Trust Fund
Issue: Promote resilience of health professionals
Issue: Support policies to address IV fluid shortages exacerbated by hurricanes, and educate Congress on the shortage of IV saline fluid and injectable drug shortage.
Issue: Oppose restrictions on fetal tissue and embryonic stem cell research.
P.L. 115-176/H.R. 5247, Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act.
Issue: Oppose Right to Try legislation that removes safety measures under FDAs current expanded access program.
S.2680, Opioid Crisis Response Act of 2018
S.2711, Enhancing Access to Addiction Treatment Act of 2018
Issue: Support policies to address the opioid epidemic including improving coverage and payment for non-opioid therapies, enhancing usability of PDMPs, addressing physician shortages, promoting medication assisted treatment, eliminating Medicare limits on in-patient psychiatric hospital treatment, eliminating Medicaid IMD exclusion, aligning privacy regulations, and investing in research and education.
Issue: Amend Controlled Substances Act to improve MAT waiver process for qualified health professionals.
H.R. 5261, Treatment, Education, and Community Help to Combat Addiction Act of 2018
Issue: Provide grants to regional Centers of Excellence in substance use disorder education.
H.R. 6082, the Overdose Prevention and Patient Safety Act
Issue: Support legislation revising 42 Code of Federal Regulations (CFR) Part 2 to amend the Public Health Service Act to align federal privacy standards for substance use disorder (SUD) patient records more closely with standards under the Health Insurance Portability and Accountability Act (HIPAA).
H.R. 6378/S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Issue: Support the Hospital Preparedness Program and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Support increased funding authorization levels.
H.R.4776 Hospital Preparedness Reauthorization Act of 2018.
Issue: Support reauthorization of the Hospital Preparedness Program
Issue: Support legislative solutions to fire arm related injuries and fatalities including research, public health surveillance, and firearm background checks.
H.R. 4392, To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Issue: Support rescission of Medicare cuts to hospitals that participate in 340B Drug Pricing Program
H.R. 4710, 340B PAUSE Act
Issue: Oppose bill that would impose a moratorium on 340B hospitals and other issues
S. 2312, 340B HELP Act
Issue: Oppose bill that would impose a moratorium and add additional reporting requirements for 340B hospitals
S.2453, Ensuring the Value of the 340B Program Act of 2018
Issue: Oppose bill that would require hospitals to report total 340B acquisition costs
H.R. 6071, Stretching Entity Resources for Vulnerable Communities Act
Issue: Support bill to rescind Medicare cuts to 340B hospitals and improve program integrity
H.R. 5598: 340B Optimization Act
Issue: Oppose bill that would change eligibility metrics in the 340B program
H.R. 6240, Drug Discount Accountability Act
Issue: Oppose bill that would impose a user fee on hospitals that participate in the 340B program
S. 3366, Maternal CARE Act
Issue: Support efforts to reduce preventable maternal mortality
H.R. 6, SUPPORT for Patients and Communities Act
Issue: Support policy eliminating Medicaid IMD exclusion and revising 42 Code of Federal Regulations (CFR) Part 2 to amend the Public Health Service Act to align federal privacy standards for substance use disorder (SUD) patient records more closely with standards under the Health Insurance Portability and Accountability Act (HIPAA).
Issue: Support policies to address the opioid epidemic including improving coverage and payment for non-opioid therapies, enhancing usability of PDMPs, addressing physician shortages, promoting medication assisted treatment, eliminating Medicare limits on in-patient psychiatric hospital treatment, eliminating Medicaid IMD exclusion, aligning privacy regulations and investing in research and education, and reauthorizing the Patient Centered Outcomes Research Institute.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), White House Office, Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS), Natl Institutes of Health (NIH), Substance Abuse & Mental Health Services Administration (SAMHSA), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Executive Office of the President (EOP), Drug Enforcement Administration (DEA), Vice President of the U.S., Office of Natl Drug Control Policy (NDCP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Len |
Marquez |
|
|
|
Tannaz |
Rasouli |
|
|
|
Jason |
Kleinman |
|
|
|
Karen |
Fisher |
J.D. |
|
|
Catherine |
Spivey |
JD |
|
|
Christa |
Wagner |
PhD |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
Executive Orders 13769 and 13780
Issue: Oppose travel suspension from affected countries and suspension of visa interview waiver program. Support policies to ensure timely and predictable processing for immigration of academic medicine community. Filed Amicus Brief with the United States Supreme Court.
S. 1615 / H.R. 3440, Dream Act of 2017
Issue: Support policies allowing undocumented students to attend U.S. medical schools and residency training. Oppose rescission of Deferred Action for Childhood Arrivals (DACA) executive action without permanent replacement. Support Dreamer eligibility for federal student loans.
P.L. 115-141, Consolidated Appropriations Act, 2018, Division M
S. 898, Conrad State 30 and Physician Access Act
Issue: Support reauthorization and expansion of the Conrad 30 J-1 visa waiver program for physicians.
Issue: Oppose separation of children from their parents at the U.S. border.
Issue: Oppose Department of Homeland Security public charge proposed rule
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Homeland Security - Dept of (DHS), State - Dept of (DOS), Health & Human Services - Dept of (HHS), U.S. Citizenship & Immigration Services (USCIS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Karen |
Fisher |
J.D. |
|
|
Tannaz |
Rasouli |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
P.L. 114-255, 21st Century Cures Act, Division A
Issue: Support implementation of 21st Century Cures Act, including the Innovation Fund, increased funding for medical research, reducing administrative and regulatory burden on scientists and research institutions, and supporting young investigators.
Issue: Regulation of Laboratory Developed Tests
Issue: Provide comments on revision to the Common Rule
17. House(s) of Congress and Federal agencies Check if None
Office of Management & Budget (OMB), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Agency for Healthcare Research & Quality (AHRQ), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Tannaz |
Rasouli |
|
|
|
Len |
Marquez |
|
|
|
Karen |
Fisher |
J.D. |
|
|
Christa |
Wagner |
PhD |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 2267/ S. 1301, Resident Shortage Physician Reduction Act of 2017
Issue: Support additional funding of graduate medical education
H.R. 5818/S.2843, Opioid Workforce Act of 2018
Issue: Support additional funding for graduate medical education for addiction medicine, addiction psychiatry, and pain management residency programs
S. 3014 Rural Physician Workforce Production Act of 2018
Issue: Oppose legislation redesigning Medicare GME payment formulas
Issues: Support lifting cap on number of residents Medicare will count when determining teaching hospitals' Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments
Issue: Oppose reduction of Medicare GME/IME payments
Issue: Oppose reduction in Medicare hospital outpatient department reimbursement.
Issue: Oppose Medicare hospital cuts
Issue: Support Medicare Graduate Medical Education (GME) per resident amount technical corrections and administrative relief.
Issue: Oppose redesign of Medicare Indirect Medical Education financing and redistribution.
Issue: Oppose overly burdensome discussion draft Medicaid GME transparency legislation as part of opioid legislative package
Issue: Submit letter and educate Congress on role of academic medicine as it relates to price transparency initiatives
S. 455, Restoring Rural Residencies Act of 2017
Issue: Support technical correction to increase access to physician services in rural communities by allowing teaching hospitals to count resident time spent in critical access hospitals for purposes of Medicare GME payments.
Issue: Development and implementation of new Medicare Disproportionate Share Hospital (DSH) formula required under the ACA.
Issue: Support allowing providers in new delivery models (e.g., ACOs, bundled payments, etc.) to access medical records with information on substance use disorders
Issue: Modify CMS Hospital Compare Star Ratings to allow stakeholders time to work together to address concerns with methodology. Support inclusion of sociodemographic status as part of quality programs
Issue: ACA Section 1115 and 1332 Medicaid Waivers
Issue: ACA Medicaid expansion. Maintain commitment to match State spending on medical care for Medicaid beneficiaries without limits, caps, or block grants. Maintain and enforce network adequacy requirements and mandate sufficient payments to providers.
Issue: Support a third agreement period for certain Accountable Care Organizations in Medicare Shared Savings Program
Issue: Support a delay in CMS issuing a final national coverage decision until the agency has an opportunity to receive and consider alternatives to limiting coverage to FDA-approved diagnostic tests developed using Next Generation Sequencing technology.
H.R. 3325/S. 428, ACE Kids Act
Issue: Support legislation to improve health care for children with complex medical conditions on Medicaid
Issue: Oppose Physician Fee Schedule rule proposal to collapse Medicare E/M coding
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Len |
Marquez |
|
|
|
Tannaz |
Rasouli |
|
|
|
Matthew |
Shick |
J.D. |
|
|
Jason |
Kleinman |
|
|
|
Karen |
Fisher |
J.D. |
|
|
Catherine |
Spivey |
JD |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
H.R. 5515, the National Defense Authorization Act for FY 2019
Issue: Oppose restrictions to Department of Defense medical research
Issue: Support reducing administrative and regulatory burden on scientists and research institutions.
Issue: Support the use of a competitive peer review process for federal research grants and programs
Issue: Support nomination of Kelvin Droegemeier, PhD to be director of White House Office of Science and Technology Policy
Issue: Support efforts to promote research integrity and address harassment in science
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Natl Institutes of Health (NIH), Natl Science Foundation (NSF), Health & Human Services - Dept of (HHS), Office of Science & Technology Policy (OSTP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Tannaz |
Rasouli |
|
|
|
Karen |
Fisher |
J.D. |
|
|
Christa |
Wagner |
PhD |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
P.L. No: 115-182, VA Maintaining Internal Systems and Strengthening Integrated Outside Networks Act of 2018 (MISSION Act)
Issue: Preserve direct sole-source contracting with academic affiliates to improve Veterans access to specialty care at academic medical centers. Support VA physician recruitment through scholarship, loan repayment, pilot programs, and immigration programs.
Issue: Support authority for VA joint ventures with academic affiliates
Issue: Support increased VA GME funding and Medicare GME funding for VA affiliates
Issue: Educate Congress on the importance of the VAs academic affiliates to improve veteran care through clinical, research, tech transfer, and education partnerships. Oppose eliminating authority for academic affiliates to administer NIH grants in support of VA investigators.
Issue: Support continuation of local flexibility and consideration of VAs statutory education and research missions in VA medical center referral determinations and procedures
17. House(s) of Congress and Federal agencies Check if None
Veterans Affairs - Dept of (VA), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Karen |
Fisher |
J.D. |
|
|
Christa |
Wagner |
PhD |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
P.L. 115-97, Tax Cuts and Jobs Creation Act
Issue: Oppose the excise tax based on investment income of private colleges and universities. Track IRS implementation of the excise tax on compensation for certain employees at tax-exempt organizations and the provision that would include name and logo royalties under unrelated business income tax
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Karen |
Fisher |
J.D. |
|
|
Catherine |
Spivey |
J.D. |
|
|
Tannaz |
Rasouli |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |